Since kinase activity does not contribute to the role of PLK2 in pyroptosis, we utilized the PLK2 kinase inhibitor TC-S7005 to stabilize PLK2 protein in AML cell lines and patient samples. This evidence concerns the gene PLK2 and acute myeloid leukemia.